Package 65219-384-02

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 65219-384-02
Digits Only 6521938402
Product NDC 65219-384
Product ID 65219-384_f3bdbd6b-0e61-43d3-8016-3edd69bedd38
Description

25 VIAL, SINGLE-DOSE in 1 CARTON (65219-384-02) / 2 mL in 1 VIAL, SINGLE-DOSE (65219-384-01)

Marketing

Marketing Status
Marketed Since 2024-11-25
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f3bdbd6b-0e61-43d3-8016-3edd69bedd38", "openfda": {"upc": ["0365219384014"], "unii": ["V3888OEY5R"], "rxcui": ["1665057"], "spl_set_id": ["38ca9270-5538-467a-a3e9-c27968f3aafe"], "manufacturer_name": ["FRESENIUS KABI USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (65219-384-02)  / 2 mL in 1 VIAL, SINGLE-DOSE (65219-384-01)", "package_ndc": "65219-384-02", "marketing_start_date": "20241125"}], "brand_name": "Verapamil Hydrochloride", "product_id": "65219-384_f3bdbd6b-0e61-43d3-8016-3edd69bedd38", "dosage_form": "INJECTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "65219-384", "generic_name": "Verapamil Hydrochloride", "labeler_name": "FRESENIUS KABI USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA216471", "marketing_category": "ANDA", "marketing_start_date": "20241125", "listing_expiration_date": "20261231"}